{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:15:48Z","timestamp":1788423348649,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,3]]},"DOI":"10.7759\/cureus.115697","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:56:42Z","timestamp":1788422202000},"source":"Crossref","is-referenced-by-count":0,"title":["Incidence, Patterns, and Predictive Factors of Biochemical Failure Following Definitive Radiotherapy for Localized Prostate Cancer: A Retrospective Military Cohort Study"],"prefix":"10.7759","author":[{"given":"Wajdi","family":"Alnajada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar M","family":"Ghnmein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan","family":"Ayyad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Abukaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher","family":"Bani Essa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laith","family":"Alhabahbeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anfal N","family":"Daheerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Alzyoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid","family":"Alhiary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/GO.20.00044","article-title":"Trends, patterns, and treatment outcomes of cancer among older patients in Jordan: a retrospective analysis of National Cancer Registry and institutional outcome data","volume":"6","author":"Abdel-Razeq H","year":"2020","unstructured":"Abdel-Razeq H, Mansour A, Bater R. Trends, patterns, and treatment outcomes of cancer among older patients in Jordan: a retrospective analysis of National Cancer Registry and institutional outcome data. JCO Glob Oncol. 2020, 6:745-51. 10.1200\/GO.20.00044","journal-title":"JCO Glob Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606220","article-title":"10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy FC","year":"2016","unstructured":"Hamdy FC, Donovan JL, Lane JA, et al.. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016, 375:1415-24. 10.1056\/NEJMoa1606220","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan JL","year":"2016","unstructured":"Donovan JL, Hamdy FC, Lane JA, et al.. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2016, 375:1425-37. 10.1056\/NEJMoa1606221","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.12.045","article-title":"Five-year outcomes of a phase 1 dose-escalation study using stereotactic body radiosurgery for patients with low-risk and intermediate-risk prostate cancer","volume":"104","author":"Zelefsky MJ","year":"2019","unstructured":"Zelefsky MJ, Kollmeier M, McBride S, et al.. Five-year outcomes of a phase 1 dose-escalation study using stereotactic body radiosurgery for patients with low-risk and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2019, 104:42-9. 10.1016\/j.ijrobp.2018.12.045","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference","volume":"65","author":"Roach M 3rd","year":"2006","unstructured":"Roach M 3rd, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, Sandler H. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference. Int J Radiat Oncol Biol Phys. 2006, 65:965-74. 10.1016\/j.ijrobp.2006.04.029","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D'Amico AV","year":"1998","unstructured":"D'Amico AV, Whittington R, Malkowicz SB, et al.. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998, 280:969-74. 10.1001\/jama.280.11.969","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000158155.33890.e7","article-title":"The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy","volume":"173","author":"Cooperberg MR","year":"2005","unstructured":"Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. 2005, 173:1938-42. 10.1097\/01.ju.0000158155.33890.e7","journal-title":"J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.08.1056","article-title":"Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure","volume":"68","author":"Ray ME","year":"2006","unstructured":"Ray ME, Levy LB, Horwitz EM, et al.. Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure. Urology. 2006, 68:1257-62. 10.1016\/j.urology.2006.08.1056","journal-title":"Urology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.24.2009","article-title":"Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals","volume":"92","author":"Platz EA","year":"2000","unstructured":"Platz EA, Rimm EB, Willett WC, Kantoff PW, Giovannucci E. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst. 2000, 92:2009-17. 10.1093\/jnci\/92.24.2009","journal-title":"J Natl Cancer Inst"},{"key":"ref11","article-title":"Molecular mechanisms involving prostate cancer racial disparity","volume":"5","author":"Karakas C","year":"2017","unstructured":"Karakas C, Wang C, Deng F, Huang H, Wang D, Lee P. Molecular mechanisms involving prostate cancer racial disparity. Am J Clin Exp Urol. 2017, 5:34-48.","journal-title":"Am J Clin Exp Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.07.006","article-title":"PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis","volume":"64","author":"Ray ME","year":"2006","unstructured":"Ray ME, Thames HD, Levy LB, et al.. PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis. Int J Radiat Oncol Biol Phys. 2006, 64:1140-50. 10.1016\/j.ijrobp.2005.07.006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-11-0322","article-title":"Racial variation in tumor stage and grade among men with prostate cancer in the U.S. Military Health System","volume":"20","author":"Enewold LR","year":"2011","unstructured":"Enewold LR, Zhou J, McGlynn KA, et al.. Racial variation in tumor stage and grade among men with prostate cancer in the U.S. Military Health System. Cancer Epidemiol Biomarkers Prev. 2011, 20:1680-7. 10.1158\/1055-9965.EPI-11-0322","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/234519","article-title":"Racial\/Ethnic patterns in prostate cancer outcomes in an active surveillance cohort","volume":"2011","author":"Cullen J","year":"2011","unstructured":"Cullen J, Brassell SA, Chen Y, Porter C, L'esperance J, Brand T, McLeod DG. Racial\/Ethnic patterns in prostate cancer outcomes in an active surveillance cohort. Prostate Cancer. 2011, 2011:234519. 10.1155\/2011\/234519","journal-title":"Prostate Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm E","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008, 61:344-9. 10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin MB","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al.. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging. CA Cancer J Clin. 2017, 67:93-9. 10.3322\/caac.21388","journal-title":"CA Cancer J Clin"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein JI","year":"2016","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016, 40:244-52. 10.1097\/PAS.0000000000000530","journal-title":"Am J Surg Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Schaeffer EM","year":"2023","unstructured":"Schaeffer EM, Srinivas S, Adra N, et al.. Prostate cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023, 21:1067-96. 10.6004\/jnccn.2023.0050","journal-title":"J Natl Compr Canc Netw"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.11.066","article-title":"Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes","volume":"71","author":"Zelefsky MJ","year":"2008","unstructured":"Zelefsky MJ, Yamada Y, Fuks Z, et al.. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys. 2008, 71:1028-33. 10.1016\/j.ijrobp.2007.11.066","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.0587","article-title":"Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9-10 prostate cancer","volume":"319","author":"Kishan AU","year":"2018","unstructured":"Kishan AU, Cook RR, Ciezki JP, et al.. Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9-10 prostate cancer. JAMA. 2018, 319:896-905. 10.1001\/jama.2018.0587","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2013.05.008","article-title":"Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapy","volume":"4","author":"Jackson WC","year":"2014","unstructured":"Jackson WC, Johnson SB, Foster B, et al.. Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapy. Pract Radiat Oncol. 2014, 4:99-107. 10.1016\/j.prro.2013.05.008","journal-title":"Pract Radiat Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-016-0656-0","article-title":"Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy","volume":"11","author":"Bracci S","year":"2016","unstructured":"Bracci S, Osti MF, Agolli L, Bertaccini L, De Sanctis V, Valeriani M. Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy. Radiat Oncol. 2016, 11:78. 10.1186\/s13014-016-0656-0","journal-title":"Radiat Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.11.044","article-title":"Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer","volume":"70","author":"Zelefsky MJ","year":"2008","unstructured":"Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Amols HI. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008, 70:1124-9. 10.1016\/j.ijrobp.2007.11.044","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.08.006","article-title":"Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy","volume":"60","author":"Goenka A","year":"2011","unstructured":"Goenka A, Magsanoc JM, Pei X, et al.. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy. Eur Urol. 2011, 60:1142-8. 10.1016\/j.eururo.2011.08.006","journal-title":"Eur Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/523994-incidence-patterns-and-predictive-factors-of-biochemical-failure-following-definitive-radiotherapy-for-localized-prostate-cancer-a-retrospective-military-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:56:43Z","timestamp":1788422203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/523994-incidence-patterns-and-predictive-factors-of-biochemical-failure-following-definitive-radiotherapy-for-localized-prostate-cancer-a-retrospective-military-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.115697","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,3]]}}}